Glossary

  • A therapy that blocks proteins involved in cell division.
  • A hospital affiliated with a university combining care, research, and teaching.
  • Scientific progress occurring more rapidly through targeted support.
  • Funding for childhood cancer research projects.
  • A drug that blocks BET proteins to suppress cancer growth.
  • A biological indicator of disease or treatment response.
  • A chemotherapy drug combination.
  • Documented patient wishes for treatment approach.
  • Detailed descriptions of individual patient treatments and outcomes.
  • A drug targeting proteins involved in cancer cell proliferation.
  • A complex of DNA and proteins in the cell nucleus that helps regulate gene expression.
  • A research study testing new ways to prevent, detect, or treat diseases.
  • Person managing clinical trial logistics.
  • A public database listing clinical trials.
  • Use of two or more treatments together.
  • Close tracking of health during a trial.
  • A field using data science to study the immune system.
  • An award from the Cancer Prevention and Research Institute of Texas.
  • A leading cancer treatment and research center in Boston.
  • Research focused on discovering and developing new treatments.
  • Requirements for joining a clinical trial.
  • Chemotherapy drugs used in combination.
  • A treatment not yet approved for general use.
  • A hybrid gene formed from two previously separate genes, often seen in cancers like NUT carcinoma.
  • DNA changes that may affect disease or treatment.
  • Inherited or acquired DNA traits of a tumor.
  • The unique set of genetic features in an individual or tumor.
  • Specialty treating cancers in the head and neck area.
  • Innovative research with high potential and uncertainty.
  • Balancing optimism with practical understanding.
  • A chemotherapy treatment plan using ifosfamide.
  • The study of how genetics influence the immune response.
  • A test to detect specific proteins in tissue.
  • A cancer treatment that helps the immune system recognize and attack cancer cells.
  • Process of understanding and agreeing to trial participation.
  • A caregiver’s deep understanding of their loved one's needs.
  • Tools for studying diseases in lab settings.
  • A coordinated effort to provide meals during medical crises.
  • A doctor who treats cancer using medication.
  • A branch of medicine focused on diagnosing and treating cancer with medications.
  • Short, intentional breaks to reset during caregiving.
  • Biological markers at a molecular level.
  • Combining multiple treatments like surgery and chemotherapy.
  • A prestigious NIH grant supporting early-career researchers.
  • A rare and aggressive cancer defined by a genetic fusion involving the NUTM1 gene, often affecting the midline structures of the body.
  • A gene that has the potential to cause cancer.
  • The study of diseases, including their causes and effects, often used to diagnose cancer.
  • A medical report based on tissue examination.
  • A nonprofit supporting patients through education and resources.
  • A platform for patients to donate tumor tissue to researchers.
  • A marker that may predict immunotherapy response.
  • Cancer care focused on children.
  • A measure of a patient's ability to perform daily activities.
  • A lab focused on tailoring immune-based therapies.
  • Medical care tailored to an individual's genetic and molecular profile.
  • Initial testing of a new treatment to determine safety.
  • Testing that focuses on whether the treatment works.
  • Charitable funding to support scientific progress.
  • Lab research before human testing.
  • Non-government financial support for research.
  • Government funds for medical and scientific studies.
  • Overall well-being during or after illness.
  • A cancer affecting fewer than 200,000 people annually in the U.S.
  • A nonprofit accelerating research for rare cancers.
  • A centralized database collecting information about individuals with a specific disease.
  • Systems and tools supporting scientific research.
  • When a tumor stops responding to treatment.
  • A chemotherapy protocol adapted for certain rare cancers.
  • Reviewing eligibility for a trial.
  • When a patient contacts a trial site on their own.
  • Unintended effects of a treatment.
  • A research grant awarded to innovative cancer researchers.
  • Advanced diagnostics like genetic sequencing used for rare cancers.
  • Routine care expenses billed to insurance.
  • A guideline for the typical treatment of a medical condition.
  • Different genetic forms of a disease.
  • Treatments to improve comfort and well-being.
  • Treatment that affects the whole body.
  • Drugs that target cancer-specific molecules.
  • Writing used as a tool for emotional wellness.
  • A medical specialty focusing on cancers of the chest area.
  • Biological material collected for research.
  • The process of creating and testing new medical treatments.
  • How a tumor reacts to a therapy.
  • The organization funding a clinical trial.
  • A facility storing tissue samples for research.
  • Specific biological aspects of a tumor.
  • An experimental BET inhibitor drug.